Relationships of uPA and VEGF Expression in Esophageal Cancer and Microvascular Density with Tumorous Invasion and Metastasis |
Jiang, Jian-Tao
(Department of Thoracic Surgery, the Second Affiliated Hospital of Medical College of XI'an Jiaotong University)
Zhang, Lan-Fang (Department of Gastroenterology, the First Affiliated Hospital of Xinxiang Medical University) Zhou, Bin (Department of Thoracic Surgery, the Second Affiliated Hospital of Medical College of XI'an Jiaotong University) Zhang, Shun-Qun (Department of Tumor, the Second Affiliated Hospital of Medical College of XI'an Jiaotong University) Li, Shao-Min (Department of Thoracic Surgery, the Second Affiliated Hospital of Medical College of XI'an Jiaotong University) Zhang, Wei (Department of Thoracic Surgery, the Second Affiliated Hospital of Medical College of XI'an Jiaotong University) Zhang, Jin (Department of Thoracic Surgery, the Second Affiliated Hospital of Medical College of XI'an Jiaotong University) Qiao, Zhe (Department of Thoracic Surgery, the Second Affiliated Hospital of Medical College of XI'an Jiaotong University) Kong, Ran-Ran (Department of Thoracic Surgery, the Second Affiliated Hospital of Medical College of XI'an Jiaotong University) Ma, Yue-Feng (Department of Thoracic Surgery, the Second Affiliated Hospital of Medical College of XI'an Jiaotong University) Chen, Sheng (Huai'an First People's Hospital, Nanjing Medical University) |
1 | Bosari S, Lee AK, Delellis RA, et al (1992). Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol, 23, 755-61. DOI ScienceOn |
2 | Cavallaro U, Tenan M, Castelli V, et al (2001). Response of bovine endothelial cells to FGF-2 and VEGF is dependenton their site of origin: Relevance to the regulation of angiogenesis. J Cell Biochem, 82, 619-33. DOI |
3 | Conn EM, Botkjaer KA, Kupriyanova TA, et al (2009). Comparative analysis of metastasis variants derived from human prostate carcinoma cells: roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasion. Am J Pathol, 175, 1638-52. DOI |
4 | Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol, 146, 1029-39. |
5 | Huang HY, Jiang ZF, Li QX, et al (2010). Inhibition of human breast cancer cell invasion by siRNA against urokinase-type plasminogen activator. Cancer Invest, 28, 689-97. DOI |
6 | Iseki K, Tat suata M, Uehara H, et al (1999). Inhibitor of angiogenesis as a mechanism for inhibitor by -hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymet hane in Wistar rat. Int Cancer, 81, 730-3. DOI |
7 | Isogai C, Laug WE, Shimada H, et al (2001). Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin. Cancer Res, 61, 5587-94. |
8 | Kang ZQ, Jiang B, Li P, Wang YJ (2003). Expression of urokinase-type plasminogen activator in non-small cell lung cancer. Academic J Second Military Medical University, 24, S4-5. |
9 | Katoh Y, Katoh M (2006). Comparative integromics on VEGF family members. Int J Oncol, 28, 1585-9. |
10 | Liu G, Zhang W, Jiang P, et al (2012). Role of nitric oxide and vascular endothelial growth factor in fluoride-induced goitrogenesis in rats. Environ Toxicol Pharmacol, 34, 209-17. DOI |
11 | Mazar AP (2008). Urokinase plasminogen activator receptor choreographs multiple ligand interaetions: implieations for tumor progression and therapy. Clin Cancer Res, 14, 5649-55. DOI |
12 | Pengchong H, Tao H (2011). Expression of IGF-1R, VEGF-C and D2-40 and their correlation with lymph node metastasis in endometrial adenocarcinoma. Eur J Gynaecol Oncol, 32, 660-4. |
13 | Qin R, Sheng X, Wu JF, Wang DB (2005). Expression of urokinase-type plasminogen activator system and vascular endothelial growth factor in human gastric cancer and the relationship with tumor invasion and metastasis. World Chin J Digestol, 13, 706-10. |
14 | Reuning U, Magdolen V, Hapke S, Schmitt M (2003). Molecular and functional interdependence ofthe urokinase-type plasminogen activatorsystem with integrins. Biol Chem, 384, 1119-31. DOI |
15 | Schmitt M, Harbeck N, Brunner N, et al (2011). Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1. Expert Rev Mol Diadn, 11, 617-34. DOI |
16 | Schmitt M, Harbeck N, Thomssen C, et al (1997). Clinical impact of the plasminogen activation and target for therapy. Thromb Haemost, 78, 285-96. |
17 | Zhang QX, Magovern CJ, Mack CA, et al (1997). Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. J Surg Res, 67, 147-54. DOI |
18 | Viacava P, Gasperi M, Acerbi G, et al (2003). Microvasscular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas. Endocrinol Invest, 26, 23-8. DOI |
19 | Xiao JP, Zhang L, Qi Y, Gong P (2007). Expression and Significance of uPA and VEGF in Breast Carcinoma. Chin J General Surgery, 16, 93-6. |
20 | Yoshizawa K, Nozaki S, Kitahara H, et al (2011). Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors. Oncol Rep, 26, 1555-60. |
21 | Zhang Y, Han J, Yang X, et al (2011). Pigment epithelium-derived factor inhibits angiogenesis and growth of gastric carcinoma by down-regulation of VEGF. Oncol Rep, 26, 681-6. |